A randomized pilot trial using a 2-way factorial design allocating patients within 72 hours of subarachnoid hemorrhage to either normovolemia ( NV ) or volume expansion ( HV ) and simultaneously to conventional ( CBP ) or augmented blood pressure ( ABP ) for 10 days .